BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24996831)

  • 41. Quality of life for patients treated for penile cancer.
    Kieffer JM; Djajadiningrat RS; van Muilekom EA; Graafland NM; Horenblas S; Aaronson NK
    J Urol; 2014 Oct; 192(4):1105-10. PubMed ID: 24747092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
    Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
    Wimberger P; Lehmann N; Kimmig R; Burges A; Meier W; Du Bois A;
    Gynecol Oncol; 2007 Jul; 106(1):69-74. PubMed ID: 17397910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genital Chlamydia trachomatis infection is related to poor sexual quality of life in young sexually active women.
    Cai T; Mondaini N; Migno S; Meacci F; Boddi V; Gontero P; Malossini G; Geppetti P; Mazzoli S; Bartoletti R
    J Sex Med; 2011 Apr; 8(4):1131-7. PubMed ID: 21269400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies.
    Camatte S; Morice P; Atallah D; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
    J Am Coll Surg; 2002 Sep; 195(3):332-8. PubMed ID: 12229940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of surgical staging on 539 patients with borderline ovarian tumors: a Turkish Gynecologic Oncology Group study.
    Guvenal T; Dursun P; Hasdemir PS; Hanhan M; Guven S; Yetimalar H; Goksedef BP; Sakarya DK; Doruk A; Terek MC; Saatli B; Guzin K; Corakci A; Deger E; Celik H; Cetin A; Ozsaran A; Ozbakkaloglu A; Kolusari A; Celik C; Keles R; Sagir FG; Dilek S; Uslu T; Dikmen Y; Altundag O; Ayhan A
    Gynecol Oncol; 2013 Dec; 131(3):546-50. PubMed ID: 24016409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome.
    Candotti G; Peiretti M; Mangili G; Bergamini A; Candiani M; Cioffi R; Mais V; Rabaiotti E; Bocciolone L
    Eur J Surg Oncol; 2020 May; 46(5):888-892. PubMed ID: 31722834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
    Chen RF; Li J; Zhu TT; Yu HL; Lu X
    J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conservative surgery for borderline ovarian tumors--emphasis on fertility preservation. A review.
    Koutlaki N; Dimitraki M; Zervoudis S; Sofiadou V; Grapsas X; Psillaki A; Nikas I; Galazios G; Liberis V; Voiculescu S; Burcoş T
    Chirurgia (Bucur); 2011; 106(6):715-22. PubMed ID: 22308907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality of life after complete lymphadenectomy for vulvar cancer: do women prefer sentinel lymph node biopsy?
    Farrell R; Gebski V; Hacker NF
    Int J Gynecol Cancer; 2014 May; 24(4):813-9. PubMed ID: 24662129
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fertility sparing surgery in early stage epithelial ovarian cancer.
    Ditto A; Martinelli F; Lorusso D; Haeusler E; Carcangiu M; Raspagliesi F
    J Gynecol Oncol; 2014 Oct; 25(4):320-7. PubMed ID: 25142621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Staging procedures fail to benefit women with borderline ovarian tumours who want to preserve fertility: a retrospective analysis of 448 cases.
    Li N; Gou J; Li L; Ming X; Hu TW; Li Z
    BMC Cancer; 2020 Aug; 20(1):769. PubMed ID: 32807135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A retrospective study of tumor and fertility outcomes after fertility-sparing surgical treatment of patients with borderline ovarian tumors].
    Liu F; Hu DH; Zhang YF; Wang B; Huang K; Wang CY; Xia XY
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3699-3703. PubMed ID: 29325322
    [No Abstract]   [Full Text] [Related]  

  • 55. Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes.
    Matsuo K; Machida H; Mandelbaum RS; Grubbs BH; Roman LD; Sood AK; Gershenson DM
    Gynecol Oncol; 2019 May; 153(2):230-237. PubMed ID: 30797590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT).
    Karlsen NMS; Karlsen MA; Høgdall E; Nedergaard L; Christensen IJ; Høgdall C
    Gynecol Oncol; 2016 Jul; 142(1):50-53. PubMed ID: 27168006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oncological and Reproductive Outcomes of Fertility-sparing Surgery in Women with Early-stage Epithelial Ovarian Carcinoma: A Multicenter Retrospective Study.
    Chen J; Wang FF; Zhang Y; Yang B; Ai JH; Wang XY; Cheng XD; Li KZ
    Curr Med Sci; 2020 Aug; 40(4):745-752. PubMed ID: 32862386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.
    Harter P; du Bois A; Hahmann M; Hasenburg A; Burges A; Loibl S; Gropp M; Huober J; Fink D; Schröder W; Muenstedt K; Schmalfeldt B; Emons G; Pfisterer J; Wollschlaeger K; Meerpohl HG; Breitbach GP; Tanner B; Sehouli J; ;
    Ann Surg Oncol; 2006 Dec; 13(12):1702-10. PubMed ID: 17009163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nomogram to predict live birth rate after fertility-sparing surgery for borderline ovarian tumours.
    Ouldamer L; Bendifallah S; Naoura I; Body G; Uzan C; Morice P; Ballester M; Daraï E
    Hum Reprod; 2016 Aug; 31(8):1732-7. PubMed ID: 27496944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fertility preservation in women with borderline ovarian tumors - how does it impact disease outcome? A cohort study.
    Helpman L; Yaniv A; Beiner ME; Aviel-Ronen S; Perri T; Ben-Baruch G; Hogen Ben-David L; Jakobson-Setton A; Korach J
    Acta Obstet Gynecol Scand; 2017 Nov; 96(11):1300-1306. PubMed ID: 28815550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.